Common adverse effects are predominantly gastrointestinal and include: Nausea (reported in 1544% of patients) Vomiting (524%) Diarrhea (830%) Constipation (1124%) Abdominal pain (520%) These effects are typically most pronounced during initial treatment and dose escalation, often diminishing over several weeks as tolerance develops
Solutions like GLP-1 tracking platforms centralize dose history, injection-site logs, symptom timing, and scheduled reminders, so users and clinicians can see the actual patterns that explain why one persons appetite returned earlier or why side effects appeared when they did
Different patients have different body types and individual needs, which means each prescription is tailored to each patient
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al
They attach the most recent clinic note and a printout of a weight chart as supporting docs